Vertex Pharmaceuticals (VRTX) Increases Despite Market Slip: Here's What You Need to KnowZacks Investment Research • 09/24/26
CRISPR Therapeutics vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/24/26
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research • 09/22/26
Vertex Announces Positive Results From Phase 2b AMPLIFIED Study of Inaxaplin in Additional Populations of People With APOL1-Mediated Kidney Disease (AMKD) and Completion of Enrollment in the Phase 2/3 AMPLITUDE TrialBusiness Wire • 09/22/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference TranscriptSeeking Alpha • 09/14/26
Vertex Pharmaceuticals Eyes Renal Growth With Key PDUFA, Pipeline Catalysts AheadMarketBeat • 09/14/26
Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 09/14/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference TranscriptSeeking Alpha • 09/10/26
Vertex Pharmaceuticals Incorporated (VRTX) Presents at Wells Fargo 21st Annual Healthcare Conference TranscriptSeeking Alpha • 09/10/26
Vertex Pharmaceuticals (VRTX) Suffers a Larger Drop Than the General Market: Key InsightsZacks Investment Research • 09/08/26
Goldman Sachs Just Added Vertex Pharmaceuticals to Its Conviction List. Here's the Bull Case for the Big Biotech StockThe Motley Fool • 09/08/26
Vertex Completes Acquisition of Crinetics Pharmaceuticals and Announces Expansion of Executive Leadership TeamBusiness Wire • 09/01/26